HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Z. Articles by Nussenblatt, R. B. Search for Related Content PubMed PubMed Citation Articles by Li, Z. Articles by Nussenblatt, R. B.

Cutting Edge: In Vivo Blockade of Human IL-2 Receptor Induces Expansion of CD56^bright Regulatory NK Cells in Patients with Active Uveitis

Zhuqing Li^*, Wee Kiak Lim^1,*,, Sankaranarayana P. Mahesh^*, Baoying Liu^* and Robert B. Nussenblatt^2,*

^* Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892; and Singapore National Eye Center, Singapore

In vivo blockade of the human IL-2R by mAb has been used for immunosuppression in transplantation, therapy for leukemia, and autoimmune diseases. In this study, we report that administration of a humanized IL-2R blocking Ab induced a 4- to 20-fold expansion of CD56^bright regulatory NK cells in uveitis patients over time. The induced CD56^bright regulatory NK cells from patients exhibited similar phenotype as those naturally occurring CD56^bright cells. Patients with active uveitis had a significantly lower level of CD56^bright NK cells compared with normal donors (p < 0.01). In addition, the induced CD56^bright cells could secrete large amounts of IL-10 whereas CD56^dim NK cells could not, suggesting that the induction of the CD56^bright cells may have a beneficial effect on the remission of active uveitis. Our observation may have implications to IL-2R blockade therapy and for the potential role of CD56^bright regulatory NK cells in autoimmune diseases.

Related articles in The JI:

Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56^bright regulatory NK cells in patients with active uveitis

Z. Li, W. K. Lim, S. P. Mahesh, B. Liu, and R. B. Nussenblatt
The JI 2005 175: 3447. [Full Text]  

This article has been cited by other articles:

				S. Yeh, Z. Li, F. Forooghian, F. S. Hwang, M. A. Cunningham, S. Pantanelli, J. C. Lew, K. K. Wroblewski, S. Vitale, and R. B. Nussenblatt CD4+Foxp3+ T-Regulatory Cells in Noninfectious Uveitis Arch Ophthalmol, April 1, 2009; 127(4): 407 - 413. [Abstract] [Full Text] [PDF]

				J. Chen, M. Zhang, W. Ju, and T. A. Waldmann Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25 Blood, February 5, 2009; 113(6): 1287 - 1293. [Abstract] [Full Text] [PDF]

				J. D. Lunemann and C. Munz Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis? Brain, July 1, 2008; 131(7): 1681 - 1683. [Full Text] [PDF]

				T. Kheradmand, P. P. Trivedi, N. A. Wolf, P. C. Roberts, and R. H. Swanborg Characterization of a subset of bone marrow-derived natural killer cells that regulates T cell activation in rats J. Leukoc. Biol., May 1, 2008; 83(5): 1128 - 1135. [Abstract] [Full Text] [PDF]

				B. Liu, Z. Li, S. P. Mahesh, S. Pantanelli, F. S. Hwang, W. O. Siu, and R. B. Nussenblatt Glucocorticoid-induced Tumor Necrosis Factor Receptor Negatively Regulates Activation of Human Primary Natural Killer (NK) Cells by Blocking Proliferative Signals and Increasing NK Cell Apoptosis J. Biol. Chem., March 28, 2008; 283(13): 8202 - 8210. [Abstract] [Full Text] [PDF]

				L. Sobrin, J. J. Huang, W. Christen, C. Kafkala, P. Choopong, and C. S. Foster Daclizumab for Treatment of Birdshot Chorioretinopathy Arch Ophthalmol, February 1, 2008; 126(2): 186 - 191. [Abstract] [Full Text] [PDF]

				P. B. Silver, R. K. Agarwal, S.-B. Su, I. Suffia, R. S. Grajewski, D. Luger, C.-C. Chan, R. M. Mahdi, J. M. Nickerson, and R. R. Caspi Hydrodynamic Vaccination with DNA Encoding an Immunologically Privileged Retinal Antigen Protects from Autoimmunity through Induction of Regulatory T Cells J. Immunol., October 15, 2007; 179(8): 5146 - 5158. [Abstract] [Full Text] [PDF]

				J. T. Snyder, J. Shen, H. Azmi, J. Hou, D. H. Fowler, and J. A. Ragheb Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine production Blood, June 15, 2007; 109(12): 5399 - 5406. [Abstract] [Full Text] [PDF]

				D. Huang, F.-D. Shi, S. Jung, G. C. Pien, J. Wang, T. P. Salazar-Mather, T. T. He, J. T. Weaver, H.-G. Ljunggren, C. A. Biron, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system FASEB J, May 1, 2006; 20(7): 896 - 905. [Abstract] [Full Text] [PDF]